Publication | Open Access

Dopamine Uses the DRD5-ARRB2-PP2A Signaling Axis to Block the TRAF6-Mediated NF-κB Pathway and Suppress Systemic Inflammation

NeuroinflammationInflammationTraf6-mediated Nf-κb PathwayPsychoneuroimmunologySuppress Systemic InflammationMedicineImmunologyImmune RegulationChronic InflammationNeuropharmacologyNeuroscienceDopaminePharmacologyDrd5-arrb2-pp2a Signaling AxisCell SignalingDopamine Research